期刊文献+

用修饰核心基因产物干扰乙型肝炎病毒基因的复制和表达 被引量:1

INHIBITION OF HEPATITIS B VIRUS GENE REPLICATION AND EXPRESSION BY MODIFIED CORE GENE PRODUCTS
下载PDF
导出
摘要 用修饰核心基因产物干扰乙型肝炎病毒基因的复制和表达袁正宏,闻玉梅,何丽芳,赵苏伶(上海医科大学医学分子病毒学实验室上海200032)关键词乙型肝炎病毒,修饰核心基因,抗病毒制剂乙型肝炎病毒(HBV)进入细胞后,其基因组的逆转录过程需在病毒核衣壳内完成... epatitis B Virus(HBV)DNA replication takes place inside the nucleocapsid via reversetranscription.It was considered that modified abnormal core proteins might compete for normal core proteins in the formation of functional nucleocapsids and hence,block thereplication of HBV DNTo test the above hypothesis, we constructed five recombinant plasmids which could separately express normal and modified HBV core proteins withinHepG2 cells.The constructs were assayed for their potential to inhibit HBV replication bycotransfection with an equal amount of HBV DNA dimer plasmid (p177,which has been proved to be able to replicate in HepG2 cells after transfection )into HepG2 cells.The replication and ex-pression of HBV DNA were determined 5 days post-transfection by Southern blot analysis of DNAs extracted from extracellular virions and detection of the HBsAg and HBeAg levels in cul-ture medium using Abbott-ELISA Kit.Results showed that modified core proteins could in-hibit HBV gene replication and expression.This study indicates that modified core proteins might develop into a novel group of anti-HBV agents.
出处 《病毒学报》 CAS CSCD 北大核心 1994年第1期68-71,共4页 Chinese Journal of Virology
基金 "863"高生物技术课题
关键词 乙型肝炎病毒 修饰核心基因 复制 Hepatitis B virus,Modified core gene products,Antivirals
  • 相关文献

参考文献5

  • 1袁正宏,病毒学报,1993年,9卷,274页
  • 2张庆五,上海医学,1993年
  • 3Tong S P,Virology,1992年,191卷,237页
  • 4袁正宏,国外医学分子生物学分册,1992年,14卷,226页
  • 5闻玉梅,中华医学杂志,1989年,69卷,260页

同被引文献11

  • 1成军,斯崇文.抗病毒基因治疗研究进展[J].中华实验和临床病毒学杂志,1993,7(4):436-439. 被引量:7
  • 2Akhtar S,Agrawal S. In vivo studies with antisense oligonuc leotides. Trends Pharmacol Sci,1997;18(1):12~18
  • 3Gewirtz AM, Sokol DL,Ratajczak MZ. Nucleic acid therapeutics: state of the art and future prospects. Blood,1998;92(3):712~736
  • 4Yacyshyn BR,Bowen-Yacyshyn MB. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology,1998;114(6):1133~1142
  • 5Agrawal S,Jiang ZN,Zhao QY et al. Mixed-backbone oligonucletid es as second ganeration antisense Oligonucleotides:in vitro and vivo studies. Proc Natl Acad Sci USA, 1997;94(6):2620~2625
  • 6Sells MA,Chen ML, Acs G. Production of hepatitis B birus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sc i USA, 1987;84(4):1005~1009
  • 7Miller RH.,Knneko S,Chung CT et al. Compact organization of the hepatitis B virus genome. Hepatology, 1989;9(2):322~324
  • 8钟森,王全立,张定凤,王升启,任红,王玉芝,陈学华,马立人.2.2.15细胞HBV基因前C和C区PCR测序及其反义寡核苷酸的抗病毒作用[J].中华肝脏病杂志,1998,6(1):10-13. 被引量:3
  • 9钟森,王升启,张定凤,王玉芝,任红,王全立.不同基因区反义寡核苷酸抑制乙型肝炎病毒基因表达的比较[J].中华传染病杂志,1998,16(1):11-13. 被引量:11
  • 10乐敏,曾玲晖,魏尔清.反义寡核苷酸药理的研究现状[J].国外医药(合成药.生化药.制剂分册),1998,19(5):259-263. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部